Publication | Open Access

Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results

Phase 1/2Neuro-oncologyRadiation Medicine5-Mm MarginsRadiation TherapyMedicineHigh-grade Gliomas5-Fraction Stereotactic RadiosurgeryClinical Radiation OncologyRadiation OncologyOncologyGliomaRadiologyHealth Sciences